Prognostic factors for adverse outcomes in patients with COVID-19: a field-wide systematic review and meta-analysis

Author:

Bellou VanesaORCID,Tzoulaki IoannaORCID,van Smeden MaartenORCID,Moons Karel G.M.,Evangelou EvangelosORCID,Belbasis LazarosORCID

Abstract

IntroductionThe individual prognostic factors for coronavirus disease 2019 (COVID-19) are unclear. For this reason, we aimed to present a state-of-the-art systematic review and meta-analysis on the prognostic factors for adverse outcomes in COVID-19 patients.MethodsWe systematically reviewed PubMed from 1 January 2020 to 26 July 2020 to identify non-overlapping studies examining the association of any prognostic factor with any adverse outcome in patients with COVID-19. Random-effects meta-analysis was performed, and between-study heterogeneity was quantified using I2 statistic. Presence of small-study effects was assessed by applying the Egger's regression test.ResultsWe identified 428 eligible articles, which were used in a total of 263 meta-analyses examining the association of 91 unique prognostic factors with 11 outcomes. Angiotensin-converting enzyme inhibitors, obstructive sleep apnoea, pharyngalgia, history of venous thromboembolism, sex, coronary heart disease, cancer, chronic liver disease, COPD, dementia, any immunosuppressive medication, peripheral arterial disease, rheumatological disease and smoking were associated with at least one outcome and had >1000 events, p<0.005, I2<50%, 95% prediction interval excluding the null value, and absence of small-study effects in the respective meta-analysis. The risk of bias assessment using the Quality in Prognosis Studies tool indicated high risk of bias in 302 out of 428 articles for study participation, 389 articles for adjustment for other prognostic factors and 396 articles for statistical analysis and reporting.ConclusionsOur findings could be used for prognostic model building and guide patient selection for randomised clinical trials.

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference32 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. Pharmacologic treatments for coronavirus disease 2019 (COVID-19);Sanders;JAMA,2020

3. World Health Organization . COVID-19 weekly epidemiological update, 16 February 2021. https://apps.who.int/iris/handle/10665/339778

4. Prognosis research strategy (PROGRESS) 4: Stratified medicine research

5. A guide to systematic review and meta-analysis of prognostic factor studies

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3